Target intelligence / Profile preview

Hepatocyte nuclear transcription machinery

Molecular classification
Transcription factor, Nuclear receptor, Protein complex
01

Overview

The hepatocyte nuclear transcription machinery refers to a complex, interconnected network of transcription factors and co-regulators that govern the liver-specific gene expression program (Odom et al., 2004). This machinery is primarily composed of the hepatocyte nuclear factors (HNFs), including HNF1α, HNF1β, HNF3 (FOXA1/2/3), HNF4α, and HNF6, which operate in a hierarchical and cross-regulatory manner to maintain hepatocyte identity and function (Kyrmizi et al., 2006; Lau et al., 2018). It plays a central role in regulating essential physiological processes such as glucose and lipid metabolism, bile acid synthesis, and the production of plasma proteins like albumin (Hayhurst et al., 2001). Dysregulation of this transcriptional network is a hallmark of various metabolic disorders, such as Maturity-Onset Diabetes of the Young (MODY), and chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (Boj et al., 2001; Yuan et al., 2009). While the machinery as a whole is a biological system rather than a single therapeutic target, individual components like HNF4α are actively pursued as targets for their ability to reprogram liver metabolism and inhibit cancer progression (Kiselyuk et al., 2012; Bogan et al., 2007).

Other names
Hepatocyte nuclear factor networkHNF transcriptional circuitryLiver-specific transcriptional machineryHNF complex
02

Mechanism of action

Modulation of the transcriptional activity of liver-specific factors, particularly HNF4A, to restore metabolic homeostasis or suppress oncogenic gene expression programs.

03

Biological functions

Liver developmentGlucose homeostasisLipid metabolismBile acid synthesisXenobiotic metabolismSerum protein production
04

Disease associations

Maturity-Onset Diabetes of the Young (MODY)Hepatocellular carcinomaNon-alcoholic fatty liver disease (NAFLD)CirrhosisHypercholesterolemia
05

Safety considerations

Systemic metabolic disruptionPotential for hepatotoxicityRisk of promoting tumorigenesis if improperly modulatedPleiotropic effects due to the large number of downstream target genes
06

Interacting drugs

BI-6015

4 more in the full profile.

07

Biomarkers

HNF4A expressionHNF1A expressionAlpha-fetoprotein (AFP)AlbuminC-reactive protein (CRP)

Beyond the preview

Go deeper on Hepatocyte nuclear transcription machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte nuclear transcription machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call